Metformin therapy in patients with diabetes mellitus is associated with a reduced risk of vasculopathy and cardiovascular mortality after heart transplantation
Cardiac allograft vasculopathy (CAV) is a major cause of morbidity and mortality following heart transplantation (HT). Reduced cardiovascular mortality and morbidity have been reported in non-HT patients treat...
Source: Cardiovascular Diabetology - Category: Cardiology Authors: Eilon Ram, Jacob Lavee, Alexander Tenenbaum, Robert Klempfner, Enrique Z. Fisman, Elad Maor, Tal Ovdat, Sergei Amunts, Leonid Sternik and Yael Peled Tags: Original investigation Source Type: research
More News: Bone Graft | Cardiology | Cardiovascular | Diabetes | Diabetes Mellitus | Endocrinology | Fortamet | Heart | Heart Transplant | Metformin | Transplants